AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2006
Jun 14, 2006
35134_dirs_2006-06-14_a1a5827d-c780-47ab-82dd-b6055eea6371.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CROFF ENTERPRISES INC (COFF)
CIK: 0000025743
Period of Report: 2006-05-15
Reporting Person: JENSEN GERALD L (Director, President, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2006-05-15 | Croff Enterprises, Inc Class B Preferred Shares | P | 5939 | $3 | Acquired | 363545 | Direct |
Footnotes
F1: This includes 149,130 shares held by Jensen Development Company and 93,354 shares held by C.S.Finance L.L.C., both of which companies are wholly owned by Gerald L. Jensen, the reporting person on this Form 4. The balance of 121,061 shares are owned personally by Gerald L. Jensen.
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Regulatory Filings
2025
Dec 16